OpGen Inc (OPGN)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
SERVICES-MEDICAL LABORATORIES
CEO:
Oliver Schacht
Employees:
100
708 QUINCE ORCHARD ROAD, SUITE 205, GAITHERSBURG, MD 20878
240-813-1260

OpGen, Inc. engages in developing and commercializing molecular microbiology solutions in the United States and internationally. Its product portfolio includes Acuitas AMR Gene Panel, an in vitro diagnostic (IVD) test for the detection and identification of various bacterial nucleic acids and genetic determinants of antimicrobial resistance (AMR) from bacterial colonies isolated from any specimen.

Data derived from most recent annual or quarterly report
Market Cap 8.381 Million Shares Outstanding46.56 Million Avg 30-day Volume 276.072 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.16
Price to Revenue4.4893 Debt to Equity0.8934 EBITDA-27.77 Million
Price to Book Value1.1026 Operating Margin-888.5474 Enterprise Value17.545 Million
Current Ratio1.115 EPS Growth0 Quick Ratio0.911
1 Yr BETA 1.1157 52-week High/Low 1.63 / 0.16 Profit Margin-980.3296
Operating Cash Flow Growth17.8045 Altman Z-Score-13.4744 Free Cash Flow to Firm -8.308 Million
View SEC Filings from OPGN instead.

View recent insider trading info

Funds Holding OPGN (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding OPGN

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Events (8k)

  • 8-K: filed on 2022-11-10:
    Item 2.02: Results of Operations and Financial Condition
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-10-03:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 3.02: Unregistered Sales of Equity Securities
    Item 3.03: Material Modifications to Rights of Security Holders
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-09-20:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-08-31:
    Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-08-11:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-07-08:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-06-24:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 1.02: Termination of a Material Definitive Agreement
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-06-09:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2022-05-24:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-05-12:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    SCHLAEPPI YVONNE

    • Director
    0 2022-11-08 2

    ELSEY R DON

    • Director
    31,500 2022-06-09 1

    RHODES WILLIAM E.

    • Director
    30,000 2022-06-09 1

    FERNANDES PRABHAVATHI

    • Director
    30,000 2022-06-09 1

    CROVETTO MARIO

    • Director
    30,000 2022-06-09 1

    BACHER JOHANNES CHIEF OPERATING OFFICER

    • Officer
    128,682 2022-03-31 3

    SCHACHT OLIVER CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    249,390 2022-03-31 2

    WEBER ALBERT CHIEF FINANICAL OFFICER

    • Officer
    210,000 2022-01-03 2

    JONES EVAN/ FA

    • Director
    23,501 2021-05-17 0

    DEC TIMOTHY C CHIEF FINANCIAL OFFICER

    • Officer
    2,093 2021-05-17 0

    CURETIS N.V. IN LIQUIDATION

    0 2020-05-07 0

    NOVA TINA SUSAN

    • Director
    750 2019-09-02 0

    USHIO MISTI

    • Director
    828 2019-09-02 0

    SAPIRO VADIM M. CHIEF INFORMATION OFFICER

    • Officer
    0 2019-05-17 0

    D'ANDREA HARRY J

    • Director
    0 2018-06-13 0

    HARRIS TIMOTHY J.R.

    • Director
    0 2018-06-13 0

    MERCK & CO., INC.

    MERCK SHARP & DOHME CORP.

    MERCK GLOBAL HEALTH INNOVATION FUND, LLC

    • 10% Owner
    No longer subject to file 2017-12-31 0

    JVEN CAPITAL, LLC CHAIRMAN AND CEO

    JONES EVAN/ FA CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    • 10% Owner
    7,555,604 2017-07-18 0

    ATWOOD BRIAN G

    • Director
    • 10% Owner
    0 2016-06-22 0

    MCCARTHY LAURENCE

    • Director
    0 2016-06-22 0

    KRENITSKY KEVIN PRESIDENT

    • Officer
    0 2016-06-13 0

    JVEN CAPITAL, LLC

    • 10% Owner
    4,679,921 2016-05-19 0

    RUBIN DAVID

    • Director
    0 2015-07-14 0

    HARRIS & HARRIS GROUP INC /NY/

    • 10% Owner
    1,710,629 2015-05-08 0

    VERSANT VENTURES III, LLC

    VERSANT VENTURE CAPITAL III, L.P.

    VERSANT SIDE FUND III, L.P.

    • 10% Owner
    2,967,543 2015-05-08 0

    HOWE TIMOTHY

    • Director
    388,328 2015-05-08 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed
    Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    SCHLAEPPI YVONNE - Director

    2022-11-10 16:24:17 -0500 2022-11-08 A 30,000 a 30,000 direct

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    OPGEN INC OPGN 2022-11-25 22:15:03 UTC -4.771 8.591 850000
    OPGEN INC OPGN 2022-11-25 21:45:04 UTC -4.771 8.591 850000
    OPGEN INC OPGN 2022-11-25 21:15:03 UTC -4.771 8.591 850000
    OPGEN INC OPGN 2022-11-25 20:45:03 UTC -4.771 8.591 850000
    OPGEN INC OPGN 2022-11-25 20:15:03 UTC -4.771 8.591 850000
    OPGEN INC OPGN 2022-11-25 19:45:04 UTC -4.771 8.591 850000
    OPGEN INC OPGN 2022-11-25 19:15:03 UTC -4.771 8.591 850000
    OPGEN INC OPGN 2022-11-25 18:45:03 UTC -4.7318 8.5518 850000
    OPGEN INC OPGN 2022-11-25 18:15:03 UTC -4.7318 8.5518 850000
    OPGEN INC OPGN 2022-11-25 17:45:04 UTC -4.7318 8.5518 850000
    OPGEN INC OPGN 2022-11-25 17:15:03 UTC -4.7318 8.5518 850000
    OPGEN INC OPGN 2022-11-25 16:45:04 UTC -4.6345 8.4545 850000
    OPGEN INC OPGN 2022-11-25 16:15:03 UTC -4.6345 8.4545 850000
    OPGEN INC OPGN 2022-11-25 15:45:03 UTC -4.6345 8.4545 850000
    OPGEN INC OPGN 2022-11-25 15:15:03 UTC -4.6345 8.4545 850000
    OPGEN INC OPGN 2022-11-25 14:45:04 UTC -4.6345 8.4545 850000
    OPGEN INC OPGN 2022-11-25 14:15:04 UTC -4.6345 8.4545 850000
    OPGEN INC OPGN 2022-11-25 13:45:03 UTC -2.8803 6.7003 850000
    OPGEN INC OPGN 2022-11-25 13:15:03 UTC -2.8803 6.7003 850000
    OPGEN INC OPGN 2022-11-25 12:45:03 UTC -2.8803 6.7003 800000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin
    Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund OPGN -4200.0 shares, $-1202.04 2022-09-30 N-PORT

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    Elevate your investments